Crohn’s & Colitis Foundation IBD Pro

Stay updated with appeal letter templates, new tools, and legislative updates to keep you on top of the stack. Join today as an #IBDPro Member. app.joinit.com/o/ibdpro/

Big change is happening in IBD research and patients are leading the way. See how real-world data and the IBD Plexus platform are reshaping treatment and fueling innovation. Download our white paper to learn more 👉 bit.ly/3FEOgRn

Precision medicine is evolving and IBD Plexus is helping lead the charge. 💥 Learn how real-world data is driving breakthroughs in Crohn’s & colitis care in our @TheEviBase feature. 🔗 becarispublishing.com/digital-conten… #IBD #PrecisionMedicine #IBDPlexus

We are thrilled to announce that @DCharabaty will be stepping up as our new Editor-In-Chief for Crohn’s & Colitis 360, along with Dr. Manasi Agrawal as our new Deputy Editor! We look forward to the continued growth of the journal under their leadership. bit.ly/3ZcGy5o

A huge thank you to our outgoing Editor-in-Chief, @MRegueiroMD, for his visionary leadership of Crohn’s & Colitis 360 over the last 7 years! We appreciate @MRegueiroMD's service & dedication to launching this open-access journal & helping it obtain the success it has today. 👏

VISIT bit.ly/IBDcareers to view more jobs!

🗞️Check out the #REACHIBD summer newsletter for #GI fellows and early-career #IBD pros. Insightful patient stories, ☀️ #stoma tips to share, and more! @fudmanMD @tqaziMD @GutlessGlamour @esna_mary @IBDProNews @CrohnsColitisFn crohnscolitisfoundation.aflip.in/REACHIBDsummer…

🌱 Tried out this new space for early-career IBD professionals, and it’s 💯 worth checking out! 💬A supportive spot to learn, connect, and share beyond the usual meetings. 📢 Early-career folks, don’t miss this! 📝 Drop your name to join!

Driving patient-centric data in #IBD research: A conversation with the @CrohnsColitisFn. @IBDProNews @IBDJournals becarispublishing.com/digital-conten…

VISIT bit.ly/IBDcareers to view more jobs!

Driving patient-centric data in #IBD research: A conversation with the @CrohnsColitisFn | @IBDProNews @IBDJournals #CrohnsColitisFoundation #IBDPlexus becarispublishing.com/digital-conten…

🚨 We’re looking for TWO leaders to Chair the 2027–2029 Crohn’s & Colitis Congress — Clinical & Basic Science tracks! 👥 Shape the program 🌎 Lead alongside experts 📍 Kickoff in Las Vegas 2026 Apply now ➡️ bit.ly/2B6lJD5 #IBD #IBDPro

👋 We’re piloting a new space for #IBD professionals to connect, share, and collaborate—outside of inboxes and events. If you’re curious, come test it out with us. Low pressure, high potential. 📝 Request an invite: forms.office.com/r/QgZFeHMGHH #LetsGoThere #IBDPro #reachibd

If you’re curious about all the new IL-23 inhibitors for IBD and why you might choose one over the other, check out our newly published review on this topic! Thank you @fudmanMD for your guidance on this article. Full text link ➡️ rdcu.be/epvFz

Key parallels and lessons that IBD can draw from today's @TheLancet cardiovascular-disease editorial The burden is shifting toward low- and middle-income countries (LMICs). More than three-quarters of all cardiovascular deaths now occur in LMICs, forcing cardiology to rethink…

Ryan Ungaro, MD, discusses the development of a risk score shown to accurately predict Crohn’s disease up to two years before its onset. @ryanungaro @DOMSinaiNYC medscape.com/viewarticle/bl…